肝臓疾患における心房細動症:流行病学と潜在的な病理生理学的メカニズム

Lavinia Alice Bălăceanu^1,2, Cristiana Grigore^1,2, Beatrice Bălăceanu-Gurău³

¹Department of Medical Semiology, "Sf. Ioan" Clinical Emergency Hospital, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.

Journal of clinical medicine

|February 13, 2026

まとめ

肝疾患は,心房細動 (AF) の患者,特に代謝機能不全に関連したステアトス性肝疾患において一般的です. これは,AFと肝臓疾患の統合管理の必要性を強調しています.

科学分野:

心臓病学心臓病学
肝臓病理学肝臓病理学
メタボリック障害メタボリック障害

背景:

動脈動 (AF) は,しばしば心代謝疾患と併発する.
AFと肝疾患,特に代謝機能不全に関連したステアトス性肝疾患 (MASLD) の間には強い関連性があります.
このAFと肝臓疾患の関連性の臨床的特徴と影響については,さらなる解明が必要である.

研究の目的:

PAROXYSMAL AFと診断された患者の肝臓の関与を特徴付けるために.
文献レビューの調査結果を,元の臨床データと統合する.
AF患者の特定の肝臓フェノタイプとその臨床関連性を特定する.

主な方法:

パロキシズム性AFを患った253人の患者の遡及分析 (2015-2025年).
人口統計データと診断の収集,肝臓病理学に焦点を当てた.
肝疾患の存在/タイプによる分層化,予測要因を見つけるための統計分析を用いる.

主要な成果:

AF患者の65.2%に肝臓疾患があり,肝臓ステアトーシス (46.2%) と肝硬変 (19.0%) が最も一般的であった.
肝臓疾患は,2型糖尿病,脂質不全,肥満,アルコールの使用率の高さに関連しています.
ディスリピデミアと肥満は独立して肝硬変を予測し,肝硬変は年齢と脂質と逆相関していた.

結論:

肝臓病理は,パーオキシズム性AF患者で非常に一般的です.
AFにおける肝疾患は,代謝および臨床プロフィールの悪影響と関連しています.
肝臓のフェノタイプを特定することで,AF患者のリスクの階層化と管理を改善することができます.

キーワード:

心房心筋病変症 (アトリアル・カーディオミオパシー)心臓メタボリックリスク肝硬変 (Cirrhosis) が発症しています.ディスリピデミア (Dyslipidemia) とは肝臓ステアトーシス肝臓ステアトーシス代謝機能障害に関連したステアトス性肝疾患

さらに関連する動画

05:12

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats

Published on: February 14, 2022

3.8K

28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.2K

関連する概念動画

01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

210

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...

210

03:03

Amyloid Fibrils

12.1K

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

12.1K

01:28

Peptic Ulcer Disease II: Pathophysiology

2.2K

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.

2.2K

01:26

Coronary Artery Disease II: Pathophysiology

540

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

540

01:26

Diseases of the Liver and Gallbladder

2.0K

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...

2.0K

01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

1.7K

Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...